Phase 1 trial evaluating GTB-3650 TriKE® continues to actively enroll, with the next update anticipated in Q3 2026 following completion of enrollment in dose Cohort 5 Phase 1 basket trial evaluating ...
Senior (LON:SNR) reported what management called a “pivotal year” in 2025, highlighted by the completion of its strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results